Cellmid Limited
Records under this name other than the patents Cellmid Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 8 of 8 · Back to Cellmid Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,128,934 | Method for Treatment or Prevention of Disease Associated with Functional Disorder of Regulatory T Cell Term ended Term ended Nov 14, 2026 · High confidence | Term ended | Term ended Nov 14, 2026 | High confidence |
| US 8,288,343 | Activation of endothelial nitric oxide synthase by midkine and uses therefor in effecting vasodilation Lapsed on the fee record Ended Oct 16, 2024 · High confidence | Lapsed on the fee record | Ended Oct 16, 2024 | High confidence |
| US 8,221,758 | Anti-Midkine Antibody for Preventing Post-Laparotomy Adhesions Term ended Term ended Mar 5, 2024 · High confidence | Term ended | Term ended Mar 5, 2024 | High confidence |
| US 8,716,230 | Methods for Treatment or Prevention of Diseases Associated with Functional Disorder of Regulatory T Cells Lapsed on the fee record Ended May 6, 2018 · Medium confidence | Lapsed on the fee record | Ended May 6, 2018 | Medium confidence |
| US 6,939,669 | Expansion of Hematopoietic Cells Using Midkine or Pleiotrophin Lapsed on the fee record Ended Sep 6, 2017 · Medium confidence | Lapsed on the fee record | Ended Sep 6, 2017 | Medium confidence |
| 15/102,502 | Method of Treatment of Alopecia with Monoterpenoids Abandoned Abandoned Aug 3, 2018 | Abandoned | Abandoned Aug 3, 2018 | |
| 16/040,360 | Method of Treatment of Alopecia with Monoterpenoids Abandoned Abandoned Nov 20, 2021 | Abandoned | Abandoned Nov 20, 2021 | |
| 16/081,081 | Methods of treating bone diseases, disorders and/or injuries and reagents therefor Abandoned Abandoned Jul 23, 2020 | Abandoned | Abandoned Jul 23, 2020 |